1. Home
  2. SNY vs SPOT Comparison

SNY vs SPOT Comparison

Compare SNY & SPOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • SPOT
  • Stock Information
  • Founded
  • SNY 1994
  • SPOT 2006
  • Country
  • SNY France
  • SPOT Luxembourg
  • Employees
  • SNY N/A
  • SPOT N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • SPOT Broadcasting
  • Sector
  • SNY Health Care
  • SPOT Consumer Discretionary
  • Exchange
  • SNY Nasdaq
  • SPOT Nasdaq
  • Market Cap
  • SNY 123.6B
  • SPOT 114.4B
  • IPO Year
  • SNY N/A
  • SPOT 2018
  • Fundamental
  • Price
  • SNY $49.90
  • SPOT $648.36
  • Analyst Decision
  • SNY Buy
  • SPOT Buy
  • Analyst Count
  • SNY 2
  • SPOT 30
  • Target Price
  • SNY $62.50
  • SPOT $597.77
  • AVG Volume (30 Days)
  • SNY 3.1M
  • SPOT 2.7M
  • Earning Date
  • SNY 04-24-2025
  • SPOT 04-29-2025
  • Dividend Yield
  • SNY 3.21%
  • SPOT N/A
  • EPS Growth
  • SNY 39.56
  • SPOT N/A
  • EPS
  • SNY 5.45
  • SPOT 6.04
  • Revenue
  • SNY $48,817,552,946.00
  • SPOT $17,538,910,500.00
  • Revenue This Year
  • SNY $5.35
  • SPOT $17.97
  • Revenue Next Year
  • SNY $6.69
  • SPOT $15.34
  • P/E Ratio
  • SNY $18.73
  • SPOT $107.44
  • Revenue Growth
  • SNY N/A
  • SPOT 17.24
  • 52 Week Low
  • SNY $45.80
  • SPOT $286.21
  • 52 Week High
  • SNY $60.12
  • SPOT $663.55
  • Technical
  • Relative Strength Index (RSI)
  • SNY 37.47
  • SPOT 60.84
  • Support Level
  • SNY $51.67
  • SPOT $540.10
  • Resistance Level
  • SNY $55.73
  • SPOT $663.55
  • Average True Range (ATR)
  • SNY 0.89
  • SPOT 27.83
  • MACD
  • SNY -0.12
  • SPOT 6.03
  • Stochastic Oscillator
  • SNY 0.34
  • SPOT 87.70

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About SPOT Spotify Technology S.A.

Spotify is the leading global music streaming service provider, with nearly 700 million monthly active users and over 250 million paying subscribers, with the latter comprising the firm's premium segment. most of the firm's revenue and nearly all its gross profit come from the subscribers, who pay a monthly fee to access a very comprehensive music library that consists of most of the most popular songs ever recorded, including all from the major record labels. The firm also sells separate audiobook subscriptions and integrates podcasts within its standard music app. Podcast content is not exclusive and is typically free to access on other platforms. Ad-supported users can access a similar music catalog but cannot customize a similar on-demand experience.

Share on Social Networks: